47325-2025 - Result
Spain – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS EFTRENONACOG ALFA, PEGCETACOPLAN, AVATROMBOPAG, ANAKINRA, VOLANESORSEN, ECULIZUMAB, SELUMETINIB, RAMUCIRUMAB, BARICITINIB, SELPERCATINIB, IXEKIZUMAB, ABEMACICLIB, DOSTARLIMAB, ASCIMINIB, INCLISIRAN, TREPROSTINIL Y TRASTUZUMAB DERUXTECAN, PRIMERA PARTE LOTES 1-16
OJ S 16/2025 23/01/2025
Contract or concession award notice – standard regime
Supplies
1. Buyer
1.1.
Buyer
Official name: SERVICIO MURCIANO DE SALUD
Email: manuel.bejarano@carm.es
Legal type of the buyer: Public undertaking, controlled by a central government authority
Activity of the contracting authority: Health
2. Procedure
2.1.
Procedure
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS EFTRENONACOG ALFA, PEGCETACOPLAN, AVATROMBOPAG, ANAKINRA, VOLANESORSEN, ECULIZUMAB, SELUMETINIB, RAMUCIRUMAB, BARICITINIB, SELPERCATINIB, IXEKIZUMAB, ABEMACICLIB, DOSTARLIMAB, ASCIMINIB, INCLISIRAN, TREPROSTINIL Y TRASTUZUMAB DERUXTECAN, PRIMERA PARTE LOTES 1-16
Description: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS EFTRENONACOG ALFA, PEGCETACOPLAN, AVATROMBOPAG, ANAKINRA, VOLANESORSEN, ECULIZUMAB, SELUMETINIB, RAMUCIRUMAB, BARICITINIB, SELPERCATINIB, IXEKIZUMAB, ABEMACICLIB, DOSTARLIMAB, ASCIMINIB, INCLISIRAN, TREPROSTINIL Y TRASTUZUMAB DERUXTECAN PRIMERA PARTE LOTES 1-16
Procedure identifier: 159380b4-c3c7-4f75-9db5-deeaf5b6ec28
Internal identifier: CS/9999/1101135926/24/EXCL
Type of procedure: Negotiated without prior call for competition
2.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
2.1.2.
Place of performance
Postal address: CALLE CENTRAL 7  
Town: MURCIA
Postcode: 30100
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
2.1.3.
Value
Estimated value excluding VAT: 97 092 217,11 EUR
2.1.4.
General information
Legal basis: 
Directive 2014/24/EU
5. Lot
5.1.
Lot: LOT-0001
Title: Eftrenonacog alfa 2000 ui vial + jeringa
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0001
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33621200 Antihaemorrhagics
Additional classification (cpv): 33621200 Antihaemorrhagics
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0002
Title: Eftrenonacog alfa 3000 ui vial + jeringa
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0002
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33621200 Antihaemorrhagics
Additional classification (cpv): 33621200 Antihaemorrhagics
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0003
Title: Eftrenonacog alfa 500 ui vial + jeringa
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0003
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33621200 Antihaemorrhagics
Additional classification (cpv): 33621200 Antihaemorrhagics
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0004
Title: Pegcetacoplan 1080 mg 8 viales sol perf
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0004
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33652300 Immunosuppressive agents
Additional classification (cpv): 33652300 Immunosuppressive agents
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0005
Title: Avatrombopag 20 mg comprimidos
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0005
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33621200 Antihaemorrhagics
Additional classification (cpv): 33621200 Antihaemorrhagics
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0006
Title: Anakinra 100 mg 7 jeringas
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0006
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33652300 Immunosuppressive agents
Additional classification (cpv): 33652300 Immunosuppressive agents
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0007
Title: Volanesorsen sodico 285 mg jer prec
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0007
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33690000 Various medicinal products
Additional classification (cpv): 33690000 Various medicinal products
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 285 120,00 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0008
Title: Eculizumab 300 mg vial solucion perfusion
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0008
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33652300 Immunosuppressive agents
Additional classification (cpv): 33652300 Immunosuppressive agents
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 6 131 547,07 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0009
Title: Selumetinib 10 mg capsulas
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0009
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33652100 Antineoplastic agents
Additional classification (cpv): 33652100 Antineoplastic agents
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 1 293 537,60 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0010
Title: Selumetinib 25 mg capsulas
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0010
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33652100 Antineoplastic agents
Additional classification (cpv): 33652100 Antineoplastic agents
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 862 513,92 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0011
Title: Ramucirumab 10 mg/ml 1 vial 10 ml concentrado perfusion
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0011
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33652100 Antineoplastic agents
Additional classification (cpv): 33652100 Antineoplastic agents
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 287 212,50 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0012
Title: Ramucirumab 10 mg/ml 1 vial 50 ml concentrado perfusion
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0012
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33652100 Antineoplastic agents
Additional classification (cpv): 33652100 Antineoplastic agents
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 2 010 487,50 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Criterios evaluables conforme a criterios objetivos o fórmulas matemáticas.
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0013
Title: Baricitinib 2 mg 28 comprimidos recubiertos
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0013
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33652300 Immunosuppressive agents
Additional classification (cpv): 33652300 Immunosuppressive agents
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 415 408,50 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0014
Title: Baricitinib 4mg 28 comprimidos recubiertos
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0014
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33652300 Immunosuppressive agents
Additional classification (cpv): 33652300 Immunosuppressive agents
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 2 567 030,40 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0015
Title: Selpercatinib 40 mg 168 capsulas duras
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0015
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33652000 Antineoplastic and immunomodulating agents
Additional classification (cpv): 33652000 Antineoplastic and immunomodulating agents
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 2 567 030,40 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
5.1.
Lot: LOT-0016
Title: Selpercatinib 80 mg 112 capsulas
Description: Suministro de medicamentos exclusivos con principios activos eftrenonacog alfa, pegcetacoplan, avatrombopag, anakinra, volanesorsen, eculizumab, selumetinib, ramucirumab, baricitinib, selpercatinib, ixekizumab, abemaciclib, dostarlimab, asciminib, inclisiran, treprostinil y trastuzumab.
Internal identifier: LOT-0016
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33652000 Antineoplastic and immunomodulating agents
Additional classification (cpv): 33652000 Antineoplastic and immunomodulating agents
5.1.2.
Place of performance
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
5.1.5.
Value
Estimated value excluding VAT: 827 738,92 EUR
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): no
5.1.10.
Award criteria
Criterion: 
Type: Price
Description: Oferta económica
Category of award weight criterion: Weight (points, exact)
Award criterion number: 100
5.1.15.
Techniques
Framework agreement: 
No framework agreement
Information about the dynamic purchasing system: 
No dynamic purchase system
5.1.16.
Further information, mediation and review
Mediation organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Review organisation: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Information about review deadlines: 15 días hábiles desde la publicación de la resolución
Organisation providing additional information about the procurement procedure: SERVICIO MURCIANO DE SALUD
Organisation providing more information on the review procedures: SERVICIO MURCIANO DE SALUD
6. Results
Value of all contracts awarded in this notice: 9 643 382,57 EUR
Direct award: 
Justification for direct award: The contract can be provided only by a particular economic operator because of exclusive rights, including intellectual property rights
Other justification: El procedimiento es negociado sin publicidad, ya que solamente puede encomendarse el objeto del presente contrato por tratarse de derechos exclusivos de varios laboratorios farmacéuticos.
6.1.
Result lot identifier: LOT-0001
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: SWEDISH ORPHAN BIOVITRUM, SL
Tender: 
Tender identifier: OFERTA-1
Identifier of lot or group of lots: LOT-0001
Value of the tender: 1 363 233,60 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0001
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS PRIMERA PARTE LOTES 1-16
Date of the conclusion of the contract: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0002
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: SWEDISH ORPHAN BIOVITRUM, SL
Tender: 
Tender identifier: OFERTA-2
Identifier of lot or group of lots: LOT-0002
Value of the tender: 1 363 228,80 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0002
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS PRIMERA PARTE LOTES 1-16
Date of the conclusion of the contract: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0003
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: SWEDISH ORPHAN BIOVITRUM, SL
Tender: 
Tender identifier: OFERTA-3
Identifier of lot or group of lots: LOT-0003
Value of the tender: 90 881,26 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0003
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS PRIMERA PARTE LOTES 1-16
Date of the conclusion of the contract: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0004
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: SWEDISH ORPHAN BIOVITRUM, SL
Tender: 
Tender identifier: OFERTA-4
Identifier of lot or group of lots: LOT-0004
Value of the tender: 380 595,60 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0004
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS PRIMERA PARTE LOTES 1-16
Date of the conclusion of the contract: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0005
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: SWEDISH ORPHAN BIOVITRUM, SL
Tender: 
Tender identifier: OFERTA-5
Identifier of lot or group of lots: LOT-0005
Value of the tender: 370 279,35 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0005
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS PRIMERA PARTE LOTES 1-16
Date of the conclusion of the contract: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0006
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: SWEDISH ORPHAN BIOVITRUM, SL
Tender: 
Tender identifier: OFERTA-6
Identifier of lot or group of lots: LOT-0006
Value of the tender: 607 797,34 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0006
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS PRIMERA PARTE LOTES 1-16
Date of the conclusion of the contract: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0007
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: SWEDISH ORPHAN BIOVITRUM, SL
Tender: 
Tender identifier: OFERTA-7
Identifier of lot or group of lots: LOT-0007
Value of the tender: 105 600,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0007
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS PRIMERA PARTE LOTES 1-16
Date of the conclusion of the contract: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0008
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: ALEXION PHARMA SPAIN, S.L.
Tender: 
Tender identifier: OFERTA-8
Identifier of lot or group of lots: LOT-0008
Value of the tender: 2 270 943,36 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0008
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS PRIMERA PARTE LOTES 1-16
Date of the conclusion of the contract: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0009
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: ALEXION PHARMA SPAIN, S.L.
Tender: 
Tender identifier: OFERTA-9
Identifier of lot or group of lots: LOT-0009
Value of the tender: 479 088,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0009
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS PRIMERA PARTE LOTES 1-16
Date of the conclusion of the contract: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0010
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: ALEXION PHARMA SPAIN, S.L.
Tender: 
Tender identifier: OFERTA-10
Identifier of lot or group of lots: LOT-0010
Value of the tender: 319 449,60 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0010
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS PRIMERA PARTE LOTES 1-16
Date of the conclusion of the contract: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0011
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: LILLY, S.A.
Tender: 
Tender identifier: OFERTA-11
Identifier of lot or group of lots: LOT-0011
Value of the tender: 106 375,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0011
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS PRIMERA PARTE LOTES 1-16
Date of the conclusion of the contract: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0012
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: LILLY, S.A.
Tender: 
Tender identifier: OFERTA-12
Identifier of lot or group of lots: LOT-0012
Value of the tender: 744 625,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0012
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS PRIMERA PARTE LOTES 1-16
Date of the conclusion of the contract: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0013
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: LILLY, S.A.
Tender: 
Tender identifier: OFERTA-13
Identifier of lot or group of lots: LOT-0013
Value of the tender: 153 855,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0013
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS PRIMERA PARTE LOTES 1-16
Date of the conclusion of the contract: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0014
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: LILLY, S.A.
Tender: 
Tender identifier: OFERTA-14
Identifier of lot or group of lots: LOT-0014
Value of the tender: 950 752,00 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0014
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS PRIMERA PARTE LOTES 1-16
Date of the conclusion of the contract: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0015
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: LILLY, S.A.
Tender: 
Tender identifier: OFERTA-15
Identifier of lot or group of lots: LOT-0015
Value of the tender: 68 978,18 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0015
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS PRIMERA PARTE LOTES 1-16
Date of the conclusion of the contract: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
6.1.
Result lot identifier: LOT-0016
Winner selection status: At least one winner was chosen.
6.1.2.
Information about winners
Winner: 
Official name: LILLY, S.A.
Tender: 
Tender identifier: OFERTA-16
Identifier of lot or group of lots: LOT-0016
Value of the tender: 306 569,98 EUR
Subcontracting: No
Contract information: 
Identifier of the contract: LOT-0016
Title: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS PRIMERA PARTE LOTES 1-16
Date of the conclusion of the contract: 08/01/2025
6.1.4.
Statistical information
Received tenders or requests to participate: 
Type of received submissions: Tenders submitted electronically
Number of tenders or requests to participate received: 1
8. Organisations
8.1.
ORG-0001
Official name: SERVICIO MURCIANO DE SALUD
Registration number: Q8050008E
Postal address: Central, nº7 Edificio Habitamia. 6ª planta. Espinardo
Town: Murcia
Postcode: 30100
Country subdivision (NUTS): Murcia (ES620)
Country: Spain
Contact point: Manuel Bejarano García
Email: manuel.bejarano@carm.es
Telephone: 968-288079
Internet address: www.murciasalud.es
Roles of this organisation: 
Buyer
Organisation providing additional information about the procurement procedure
Organisation providing more information on the review procedures
8.1.
ORG-0002
Official name: Tribunal Administrativo Central de Recursos Contractuales del Ministerio de Hacienda y Administraciones Públicas
Registration number: Q6152336Z
Postal address: Avenida General Peron 38
Town: Madrid
Postcode: 28071
Country subdivision (NUTS): Madrid (ES300)
Country: Spain
Email: tribunal_recursos.contratos@hacienda.gob.es
Telephone: 91 3491451
Roles of this organisation: 
Review organisation
Mediation organisation
8.1.
ORG-0003
Official name: SWEDISH ORPHAN BIOVITRUM, SL
Registration number: B84710623
Postal address: CALLE PRINCIPE DE VERGARA, 1º A
Town: Madrid
Postcode: 28001
Country subdivision (NUTS): Madrid (ES300)
Country: Spain
Email: ana.martin@sobi.com
Telephone: 913913580
Roles of this organisation: 
Tenderer
Winner of these lots: LOT-0001, LOT-0002, LOT-0003, LOT-0004, LOT-0005, LOT-0006, LOT-0007
8.1.
ORG-0004
Official name: ALEXION PHARMA SPAIN, S.L.
Registration number: B64494784
Postal address: Av. diagonal, 1º
Town: BARCELONA
Postcode: 08028
Country subdivision (NUTS): Barcelona (ES511)
Country: Spain
Email: xavier.millanbarbera@alexion.com
Telephone: 932723038
Roles of this organisation: 
Tenderer
Winner of these lots: LOT-0008, LOT-0009, LOT-0010
8.1.
ORG-0005
Official name: LILLY, S.A.
Registration number: A28058386
Postal address: CALLE INDUSTRIA, 30
Town: ALCOBENDAS
Postcode: 28100
Country subdivision (NUTS): Madrid (ES300)
Country: Spain
Email: ar.spain@lilly.com
Telephone: 902 338300
Roles of this organisation: 
Tenderer
Winner of these lots: LOT-0011, LOT-0012, LOT-0013, LOT-0014, LOT-0015, LOT-0016
8.1.
ORG-0000
Official name: Publications Office of the European Union
Registration number: PUBL
Town: Luxembourg
Postcode: 2417
Country subdivision (NUTS): Luxembourg (LU000)
Country: Luxembourg
Email: ted@publications.europa.eu
Telephone: +352 29291
Internet address: https://op.europa.eu
Roles of this organisation: 
TED eSender
Notice information
Notice identifier/version: 4abe721c-a9dc-449c-b094-142857c4c2bc  -  01
Form type: Result
Notice type: Contract or concession award notice – standard regime
Notice subtype: 29
Notice dispatch date: 22/01/2025 12:01:45 (UTC+00:00) Western European Time, GMT
Languages in which this notice is officially available: Spanish
Notice publication number: 47325-2025
OJ S issue number: 16/2025
Publication date: 23/01/2025